Prognostic factors add criteria to treat Waldenstrom's macroglobulinemia.

被引：0
作者：
Morel, P
Duhamel, A
Dimopoulos, M
San Miguel, J
Barlogie, B
Kyle, R
Leblond, V
Dhodapkar, M
Mc Coy, J
Treon, S
Gobbi, PG
Merlini, G
机构：
[1] Hop Schaffner, Lens, France
[2] Univ Hosp, Ctr Etud & Rech Informat Med, Lille, France
[3] Univ Athens, Athens, Greece
[4] Hosp Univ, Salamanca, Spain
[5] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[6] Mayo Clin, Rochester, MN USA
[7] Hop La Pitie Salpetriere, Paris, France
[8] SW Oncol Grp, Seattle, WA USA
[9] Dana Farber Canc Inst, Boston, MA 02115 USA
[10] IRCCS Policlin San Matteo, Biotechnol Res Labs, Pavia, Italy
[11] Univ Pavia, I-27100 Pavia, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：261 / 262
页数：2
相关论文
共 50 条
  • [31] Fludarahine, mitoxantrone and dexamethasone in the treatment of refractory Waldenstrom's macroglobulinemia.
    Rauch, A
    Pasion, A
    BLOOD, 1997, 90 (10) : 4139 - 4139
  • [32] Update of bolus administration of cladribine in the treatment of Waldenstrom's macroglobulinemia.
    Hampshire, A
    Saven, A
    BLOOD, 2003, 102 (11) : 402A - 402A
  • [33] Waldenstrom's macroglobulinemia: prognostic factors and recent therapeutic advances
    Leblond, V
    Tournilhac, O
    Morel, P
    CLINICAL AND EXPERIMENTAL MEDICINE, 2004, 3 (04) : 187 - 198
  • [34] Bcl-2 antisense treatment for Waldenstrom's macroglobulinemia.
    Nichols, GL
    Lin, N
    Sur, M
    Benimetskaya, L
    Stein, CA
    BLOOD, 2002, 100 (11) : 579A - 579A
  • [35] Combination therapy with rituximab and fludarabine is highly active in Waldenstrom's macroglobulinemia.
    Treon, SP
    Wasi, P
    Emmanouilides, CA
    Frankel, SR
    Kimby, E
    Lister, A
    Morel, P
    Kelliher, A
    Branagan, A
    Preffer, F
    Anderson, KC
    BLOOD, 2002, 100 (11) : 211A - 211A
  • [36] Serum free light chain in waldenstrom macroglobulinemia.
    Moreau, Anne-Sophie
    Leleu, Xavier
    Manning, Robert
    Coiteux, Valerie
    Darre, Stephane
    Hatjiharisi, Evdoxia
    Hunter, Zachary
    Jia, Xiaoying
    Ngo, Hai
    O'Sullivan, Garrett
    Santos, Daniel
    Treon, Steven
    Facon, Thierry
    Anderson, Kenneth
    Ghobrial, Irene
    BLOOD, 2006, 108 (11) : 685A - 685A
  • [37] Analysis of chemokine and adhesion markers in waldenstrom macroglobulinemia.
    Ngo, Hai T.
    Leleu, Xavier
    Moreau, Anne-Sophie
    Hatjiharissi, Evodoxia
    Jia, Xiaoying
    O'Sullivan, Garrett
    Runnels, Judith
    Villarreal, Rose
    Hunter, Zachary
    Treon, Steven
    Hideshima, Teru
    Anderson, Kenneth
    Ghobrial, Irene
    BLOOD, 2006, 108 (11) : 244B - 244B
  • [38] How we treat Waldenstrom's macroglobulinemia
    Dimopoulos, MA
    Merlini, G
    Leblond, V
    Anagnostopoulos, A
    Alexanian, R
    HAEMATOLOGICA, 2005, 90 (01) : 117 - 125
  • [39] Role of B-lymphocyte stimulator (BLyS) in Waldenstrom's macroglobulinemia.
    Elsawa, SF
    Novak, AJ
    Grote, DM
    Zeismer, SC
    Witzig, TE
    Kyle, RA
    Ansell, SM
    BLOOD, 2005, 106 (11) : 178A - 179A
  • [40] Sildenafil citrate suppresses disease progression in patients with Waldenstrom's macroglobulinemia.
    Patterson, C. J.
    Soumerai, J.
    Hunter, Z.
    Leleu, X.
    Ghobrial, I.
    Treon, S. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 435S - 435S
12345